After moving 7.5% or more over a ten-day period, the stock rose in the next ten days only on 41% of the occasions After moving 28.0% or more over a twenty-one-day period, the stock rose in the next twenty-one days only on 43% of the occasions. While SRNE stock declined over 8% from levels of $9.46 on June 14 to $8.69 on June 21, it has since rallied 14% to $9.90 now. Out of 416 instances in the last ten years that SRNE stock saw a twenty-one day rise of 28% or more, 236 of them resulted in SRNE stock declining over the subsequent one month period (twenty-one trading days). Shares of the drugmaker fell 7.04% to $103.8 in early trading. Shares of the drugmaker fell 7.04% to $103.8 in early trading.
while nationwide production of competitive drugs is up to 350% from a year ago..
( z0 contrast :rel ( z1 produce :ARG2 ( z2 up-to :op ( z3 percentage-entity :value 350 ) ) :location ( z4 nationwide ) ) :rel ( z5 produce :ARG1 ( z6 drug :ARG0-of ( z7 compete ) ) :time ( z8 before :quant ( z9 temporal-quantity :quant 1 :unit ( z10 year ) ) :op ( z11 now ) ) ) )
(z0 / contrast-01
    :rel (z1 / produce-01
             :ARG2 (z2 / up-to
                       :op1 (z3 / percentage-entity
                                :value 350))
             :location (z4 / nationwide))
    :rel (z5 / produce-01
             :ARG1 (z6 / drug
                       :ARG0-of (z7 / compete-01))
             :time (z8 / before
                       :quant (z9 / temporal-quantity
                                  :quant 1
                                  :unit (z10 / year))
                       :op1 (z11 / now))))
while nationwide production of competitive drugs is up to 350 % from a year ago ..
z1 :location z4
z6 :ARG0-of z7
z5 :ARG1 z6
z1 :ARG2 z2
z3 :value 1
z2 :op1 z3
z9 :quant 0
z9 :unit z10
z8 :quant z9
z5 :time z8
z8 :op1 z11
z0 :rel z1
z0 :rel z5